Man så obliterativ bronchiolitis i 21, 7% af patienterne i tacrolimus sammenlignet med 38, 0% af patienterne i ciclosporingruppen (p=0, 025).
Obliterative bronchiolitis developed in 21.7% of patients in the tacrolimus group compared with 38.0% of patients in the ciclosporin group (p = 0.025).